Venture Investments
Investing in Revolutionary Technologies to Cure Disease, Improve Nutrition, and Enhance the Future of Human Health
Alexandria Ventures® is the company's strategic venture capital platform. Since our inception in 1996, we have invested in disruptive life science companies that are advancing transformative new modalities, platforms, and innovative medicines to meaningfully improve human health.
Our venture activity provides deep insights into key macro life science industry and innovation trends; builds and nurtures strong relationships with serial entrepreneurs, world-renowned academic institutions, and venture investors; and further enhances the high-quality tenant base we have diligently cultivated over many years.
Track Record
#1
MOST ACTIVE CORPORATE INVESTOR IN BIOPHARMA FOR SIX CONSECUTIVE YEARS
Ranked by Silicon Valley Bank (By new deal volume)
TOP 5
MOST ACTIVE U.S.
INVESTORS IN
AGRIFOODTECH FOR THREE CONSECUTIVE YEARS
Ranked by AgFunder
(By number of companies
invested in)
$506M
On-Balance Sheet
Unrealized Gains*
$1.2B
Adjusted Cost
Basis*
* As of December 31, 2022.
Partnering With Trailblazing Companies to Drive Transformative Innovation